BioGaia signs agreement for France

BioGaia has signed a distribution agreement with the French company Laboratoires BIOETHIC. The agreement gives Laboratoires BIOETHIC exclusive rights to sell BioGaia's Probiotic drops and tablets in France. The products will be sold under the BioGaia brand.



"Given BioGaia's extensive clinical studies in the area and the large sales force that will work with BioGaia's products on the French market, we at Laboratoires BIOETHIC have high expectations for this collaboration." says Frédéric Derome, Managing Director, Laboratoires BIOETHIC.

The launch of BioGaia's Probiotic drops, containing Lactobacillus reuteri, in France is planned in Autumn 2009, whilst tablet sales will start Spring 2010.

"We are happy to have contracted a distributor in France who work according to our now well-established model with the BioGaia brand, especially since we consider that France can become an important market for us." says Peter Rothschild, Managing Director, BioGaia.








Latest press releases from BioGaia:
2009-09-17 Personnel changes at BioGaia
2009-08-18 BioGaia AB Interim report 1 January - 30 June 2009
2009-06-30 BioGaia signs new agreement with Semper for unique probiotic Oral Rehydration Solution (ORS)

For additional information contact:
Peter Rothschild, Managing Director, telephone: +46 8 -555 293 00
Jan Annwall, Deputy Managing Director, telephone: +46 8-555 293 00

BioGaia is a biotechnology company that develops, markets and sells probiotic products
with documented health benefits. The products are primarily based on the lactic acid
bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects.
The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list
of the NASDAQ OMX Nordic Exchange Stockholm.
www.biogaia.com

About Us

BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri, which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com If you need more information about BioGaia and our products please visit our website or download our press kit from: http://www.biogaia.com/press-material

Subscribe

Documents & Links